Women's Health

Effect of the ‘Mother and Baby’ Program on Well-Being
Research and Trials 01 Jan 2013

Effect of the ‘Mother and Baby’ Program on Well-Being

The study investigates the effect of the ‘Mother and Baby’ (M&B) program on the psychological health and well-being of new mothers 6-10 weeks following the birth of their baby. The M&B program is an 8-week program of group exercise and education sessions provided by various health professionals. The design of…
Study Evaluating the Safety and Efficacy of ERB-041 on Reduction of Symptoms Associated With Endometriosis in Reproductive-Aged Women
Research and Trials 01 Jan 2013

Study Evaluating the Safety and Efficacy of ERB-041 on Reduction of Symptoms Associated With Endometriosis in Reproductive-Aged Women

The purpose of the study is to evaluate the efficacy and safety of two doses of ERB-041 (75 mg and 150 mg) relative to placebo on the relief of endometriosis-related symptoms (dysmenorrhea, pelvic pain, and deep dyspareunia) in reproductive aged women. Official Title A Double-Blind, Randomized, Placebo-Controlled Study to Evaluate…
Goserelin in Preventing Ovarian Failure in Women Receiving Chemotherapy for Breast Cancer
Cancer 01 Jan 2013

Goserelin in Preventing Ovarian Failure in Women Receiving Chemotherapy for Breast Cancer

Goserelin blocks hormone production in the ovaries. It is not yet known whether ovarian suppression using goserelin will prevent ovarian failure (early menopause) in women receiving chemotherapy for breast cancer. This randomized phase III trial is studying how well giving goserelin together with chemotherapy works compared with chemotherapy alone in…
A Phase II Study Evaluating SB-751689 in Post-Menopausal Women With Osteoporosis.
Research and Trials 01 Jan 2013

A Phase II Study Evaluating SB-751689 in Post-Menopausal Women With Osteoporosis.

This is a 12 month study designed to evaluate the safety and effectiveness of SB-751689 in the treatment of osteoporosis in post-menopausal women, in comparison with 2 active comparators and placebo. Official Title Study CR9108963: A Dose-Range Finding Study of SB-751689 in Post-Menopausal Women With Osteoporosis Conditions Osteoporosis Study Type…
Effect of Teriparatide Compared to Risedronate on Back Pain in Women With a Spine Fracture Caused by Osteoporosis
Research and Trials 01 Jan 2013

Effect of Teriparatide Compared to Risedronate on Back Pain in Women With a Spine Fracture Caused by Osteoporosis

The purpose of the study is to determine if daily teriparatide reduces back pain more effectively than weekly risedronate in postmenopausal women with osteoporosis that have back pain due to a spinal bone fracture. Official Title The Effect of Teriparatide Compared With Risedronate on Back Pain in Postmenopausal Women With…
A Study to Evaluate AMG 162 in the Treatment of Postmenopausal Osteoporosis
Research and Trials 01 Jan 2013

A Study to Evaluate AMG 162 in the Treatment of Postmenopausal Osteoporosis

This study will evaluate the effectiveness and safety of AMG 162 in treating women with Postmenopausal Osteoporosis. Official Title Conditions Osteoporosis Study Type Interventional Study Design Treatment Further Details Primary Outcome Measures: Reduction in the number of new vertebral fractures in post menopausal osteoporotic women treated with AMG…
PROMPT Clinical Trial for Migraine Prevention
Research and Trials 01 Jan 2013

PROMPT Clinical Trial for Migraine Prevention

Various national and local guidelines demand revision of migraine prevention therapy after 4 to 6 months of treatment. However, there is no evidence from clinical studies to support the validity of such guidance. The PROMPT (PROlonged Migraine Prevention with Topiramate) study was set up to address this issue and evaluate…
Open Label Tolerability and Safety Study of KRX-101 in Australia, New Zealand, and Hong Kong
Research and Trials 01 Jan 2013

Open Label Tolerability and Safety Study of KRX-101 in Australia, New Zealand, and Hong Kong

The purpose of this study is to assess the tolerability and safety of KRX-101 in treating persistent microalbuminuria in type 2 diabetic patients who are also being treated with stable, maximum tolerated doses of either ACE inhibitors or A2 receptor blockers. Official Title An Open Label Tolerability and Safety Study…
Research and Trials 01 Jan 2013

Amlodipine/Atorvastatin Combination to Reduce the Health Risk of High Blood Pressure and High Cholesterol Levels

The purpose of the study is to measure the effect of the amlodipine/atorvastatin combination pill in reducing both elevated blood pressure and cholesterol levels to levels suggested by guidelines Official Title Clinical Utility of Amlodipine/Atorvastatin to Improve Concomitant Cardiovascular Risk Factors of Hypertension and Dyslipidemia Conditions Hypertension, Hyperlipidemia Study Type…